Strata Critical Medical Inc. Class A (SRTA)
NASDAQ: SRTAHealth CareMedical/Nursing ServicesUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
SRTA stock chart
Technical analysisKey statistics
All statistics- Market cap
- $407.30M
- EPS (TTM)
- -$0.24
- Dividend yield
- None
- 52-week range
- 3.95 – 6.50
- Day range
- 4.54 – 4.85
- Volume / Avg
- 1.13M / 982.75K
- Beta
- —
- Shares outstanding
- 89.32M
52-week range
SRTA stock today
Strata Critical Medical (SRTA) closed at $4.56 on Nov 20, down 5.59% (-$0.27), versus the S&P 500's 3.70% decline. At this level, SRTA sits in the middle of its 52-week range of $3.95 to $6.50: 29.8% below the high, set on May 28, 2026 and 15.4% above the low. SRTA is down 5.2% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 8.6%.
Strata Critical Medical has posted a net loss over the last twelve months (EPS of -$0.24), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About Strata Critical Medical
Company profileStrata Critical Medical, Inc. provides time-critical logistics and medical services to the healthcare industry in the United States. It operates in two segments, Logistics and Clinical.
- Sector
- Health Care
- Industry
- Medical/Nursing Services
- CEO
- Ms. Melissa M. Tomkiel J.D.
- Headquarters
- New York, NY
- Employees
- 327
- IPO year
- 2019
- Website
- stratacritical.com
Financial highlights
Full financialsIn fiscal 2025, Strata Critical Medical generated $197.1 million in revenue, up 34.3% from fiscal 2024. Net income was $41.3 million, for a net margin of 21.0% versus a median of -21.8% in the prior 5 years. Gross margin was 20.9% (up from 20.2%) and operating margin -11.3%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $197.14M | $146.82M | $225.18M | $146.12M | $50.53M |
| Growth | +34.28% | -34.80% | +54.11% | +189.20% | — |
| Net income | $41.35M | $-27.31M | $-56.08M | $-27.26M | $-40.05M |
| EPS (diluted) | $0.50 | $-0.35 | $-0.76 | $-0.38 | $-0.93 |
Analyst forecast
ForecastConsensus (4 analysts)
strong_buy
Avg. price target
$9.63+111.18%
- Strong buy 0
- Buy 4
- Hold 0
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Sep/2026)
- Nov 3, 2026
- EPS actual vs est.
- $-0.09 vs $0.01
- Surprise
- -1000.00%
SRTA news
All SRTA newsStrata Critical Medical peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| PIIIP3 Health Partners Inc. Class A | 1.69 | -9.14% | $350.24M | vs SRTA |
| STLNStarling Oncology Inc. | 3.00 | -5.66% | $305.97M | vs SRTA |
| SBCSBC Medical Group Holdings Incorporated | 5.17 | -7.68% | $530.32M | vs SRTA |
| AUNAAuna SA Class A | 3.66 | -6.15% | $271.05M | vs SRTA |
| OMDAOmada Health Inc. | 11.87 | -5.04% | $736.39M | vs SRTA |
| LFMDLifeMD Inc. | 1.45 | -9.40% | $69.84M | vs SRTA |
| NAKANakamoto Inc. | 3.44 | -15.89% | $63.11M | vs SRTA |
| EUDAEUDA Health Holdings Limited Class A | 15.96 | -7.69% | $47.79M | vs SRTA |
Indexes, lists and sector
Strata Critical Medical stock FAQ
What is Strata Critical Medical's stock price today?
SRTA last traded at $4.56 as of Nov 20, 4:00 PM EST, down 5.59% on the day. Prices are delayed at least 15 minutes.
Who is Strata Critical Medical's CEO?
Ms. Melissa M. Tomkiel J.D. is the chief executive officer of Strata Critical Medical Inc. Class A, which has about 327 employees.
What is the SRTA 52-week high?
The 52-week high for SRTA is $6.50 and the 52-week low is $3.95. The stock is currently 29.8% below its high.